B. Gahn

1.1k total citations
21 papers, 775 citations indexed

About

B. Gahn is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, B. Gahn has authored 21 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 8 papers in Genetics. Recurrent topics in B. Gahn's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). B. Gahn is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (8 papers) and Chronic Lymphocytic Leukemia Research (7 papers). B. Gahn collaborates with scholars based in Germany, United States and Pakistan. B. Gahn's co-authors include Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Catherine M. Bollard, M. Helen Huls, Wolfgang Hiddemann, Adrian P. Gee, George Carrum, Laura K. Aguilar and Melissa M. Hudson and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

B. Gahn

21 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Gahn Germany 12 455 295 294 137 127 21 775
John Strehl Germany 15 550 1.2× 283 1.0× 327 1.1× 259 1.9× 72 0.6× 32 1.0k
Leo M. Budel Netherlands 13 332 0.7× 242 0.8× 161 0.5× 70 0.5× 107 0.8× 24 780
Beatrice D. Spector United States 8 354 0.8× 240 0.8× 352 1.2× 132 1.0× 102 0.8× 10 892
Meifeng Tu China 12 471 1.0× 313 1.1× 200 0.7× 90 0.7× 126 1.0× 65 747
Sridhar Chaganti United Kingdom 18 617 1.4× 433 1.5× 235 0.8× 104 0.8× 138 1.1× 61 944
RK Brynes United States 19 451 1.0× 555 1.9× 375 1.3× 325 2.4× 324 2.6× 37 1.2k
Mohammad A. Vasef United States 20 591 1.3× 458 1.6× 116 0.4× 160 1.2× 105 0.8× 52 1.0k
Sumana Devata United States 15 347 0.8× 279 0.9× 267 0.9× 86 0.6× 175 1.4× 52 778
AM Levine United States 15 339 0.7× 297 1.0× 204 0.7× 156 1.1× 290 2.3× 22 893
Marco Ungari Italy 15 483 1.1× 151 0.5× 264 0.9× 84 0.6× 61 0.5× 53 978

Countries citing papers authored by B. Gahn

Since Specialization
Citations

This map shows the geographic impact of B. Gahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Gahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Gahn more than expected).

Fields of papers citing papers by B. Gahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Gahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Gahn. The network helps show where B. Gahn may publish in the future.

Co-authorship network of co-authors of B. Gahn

This figure shows the co-authorship network connecting the top 25 collaborators of B. Gahn. A scholar is included among the top collaborators of B. Gahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Gahn. B. Gahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thuss‐Patience, Peter, Ralf‐Dieter Hofheinz, Dirk Arnold, et al.. (2012). Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Annals of Oncology. 23(11). 2827–2834. 56 indexed citations
2.
Repp, Roland, Annette Günther, H. Schade, et al.. (2008). BEAM-alemtuzumab followed by allogeneic SCT for the treatment of relapsed or refractory T-NHL. Journal of Clinical Oncology. 26(15_suppl). 8552–8552. 1 indexed citations
3.
Gahn, B., Natalie Schub, Reinald Repp, & Martin Gramatzki. (2007). Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.. PubMed. 12(8). 337–40. 3 indexed citations
4.
Hoffmann, Christian, Roland Repp, Robert Schoch, et al.. (2006). Successful autologous stem cell transplantation in a severely immunocompromised patient with relapsed AIDS-related B-cell lymphoma.. PubMed. 11(2). 73–6. 3 indexed citations
5.
Pott, Christiane, Carsten Schrader, Stefan Gesk, et al.. (2005). Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood. 107(6). 2271–2278. 121 indexed citations
6.
Bollard, Catherine M., Laura K. Aguilar, Karin Straathof, et al.. (2004). Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease. The Journal of Experimental Medicine. 200(12). 1623–1633. 285 indexed citations
7.
Schmook, Tobias, et al.. (2003). Remarkable remission of a follicular lymphoma treated with rituximab and polychemotherapy (CHOP). Clinical and Experimental Dermatology. 28(1). 31–33. 6 indexed citations
8.
Krüger, Stefan, Roland Schroers, Cliona M. Rooney, B. Gahn, & Si–Yi Chen. (2003). Identification of a Naturally Processed HLA-DR–Restricted T-Helper Epitope in Epstein-Barr Virus Nuclear Antigen Type 1. Journal of Immunotherapy. 26(3). 212–221. 27 indexed citations
9.
10.
Gahn, B., et al.. (2002). Immunotherapy to reconstitute immunity to DNA viruses. Seminars in Hematology. 39(1). 41–47. 11 indexed citations
11.
Rooney, Cliona M., Catherine M. Bollard, M. Helen Huls, et al.. (2002). Immunotherapy for Hodgkin's disease.. PubMed. 81 Suppl 2. S39–42. 24 indexed citations
12.
Gahn, B., Fernando Siller-López, Eric Yvon, et al.. (2001). Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. International Journal of Cancer. 93(5). 706–713. 65 indexed citations
13.
Gahn, B., G. Brittinger, Gottfried Dölken, et al.. (2000). Multicenter Phase II Study of Oral Idarubicin in Treated and Untreated Patients with B-Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 37(1-2). 169–173. 2 indexed citations
14.
15.
Gahn, B., et al.. (1999). Analysis of progenitor cell involvement in B‐CLL by simultaneous immunophenotypic and genotypic analysis at the single cell level. British Journal of Haematology. 105(4). 955–959. 14 indexed citations
16.
Haase, Dagmar, Michaela Feuring‐Buske, Claudia Schoch, et al.. (1997). Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia. 11(5). 674–679. 32 indexed citations
17.
Gahn, B., Jakob Neef, C. Troff, et al.. (1997). Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia. Blood. 89(12). 4275–4281. 36 indexed citations
18.
Gahn, B., et al.. (1997). . Annals of Oncology. 8(2+). 55–57. 2 indexed citations
19.
Gahn, B., Jakob Neef, C. Troff, et al.. (1997). Detection of trisomy 12 in CD34+ progenitor cells in a patient with B-cell chronic lymphocytic leukemia by florescence in situ hybridization. Annals of Oncology. 8. S55–S57. 1 indexed citations
20.
Gahn, B., Dagmar Haase, Michael Unterhalt, et al.. (1996). De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.. PubMed. 10(6). 946–51. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Strehl Breakdown of academic impact, for papers by Leo M. Budel Breakdown of academic impact, for papers by Beatrice D. Spector Breakdown of academic impact, for papers by Meifeng Tu Breakdown of academic impact, for papers by Sridhar Chaganti Breakdown of academic impact, for papers by RK Brynes Breakdown of academic impact, for papers by Mohammad A. Vasef Breakdown of academic impact, for papers by Sumana Devata Breakdown of academic impact, for papers by AM Levine Breakdown of academic impact, for papers by Marco Ungari
Rankless by CCL
2026